Tweenvest Stocks

Gelesis Holdings, Inc. (OTCPK: GLSH.Q)

Health Care · Biotechnology · US

$0.00

— today · -99.0% 1Y

Gelesis Holdings, Inc. (OTCPK: GLSH.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $73.00 and employs 93 people.

Over the last twelve months the share price has lost 99.0%, trading between 0.00 and 0.00.

Tweenvest scores Gelesis Holdings, Inc. across four factors: quality 13/100, value 45/100. Its strongest factor is value.

GLSH.Q price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$73.00
Revenue (TTM)
$12.14M
P/E
—
EPS
-0.71
Dividend yield
—
Beta (5Y)
3,282.48
52-week high
$0.00
52-week low
$0.00
Avg volume (3M)
—
Shares outstanding
73.34M
Employees
93
Next earnings
—

About Gelesis Holdings, Inc.

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.

ISIN
US36850R2040
Founded
2006
Listed since
Jan 14, 2022
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Lattice Biologics Ltd.OTCPK: LBLT.F$128.00$——
Infinity Pharmaceuticals, Inc.OTCPK: INFI.Q$91.00$0.00-99.00%
RenovaCare, Inc.OTCPK: RCAR$87.00$0.00—
Statera Biopharma, Inc.OTCPK: STAB$73.00$0.00-99.00%
Athersys, Inc.OTCPK: ATHX.Q$62.00$0.00-90.00%
Genocea Biosciences, Inc.OTCPK: GNCA.Q$59.00$——
Mymetics CorporationOTCPK: MYMX$46.00$——
Rebus Holdings, Inc.OTCPK: RBSH$32.00$0.00—

Browse every Biotechnology company →

Figures last refreshed Oct 4, 2026.